Dr. Mazumder's research centers on predicting outcome for patients with liver disease. Specifically, his interest is in the interplay between the pathophysiology of portal hypertension and the cardio-renal axis as it applies to personalizing care for patients. He is interested in mathematical modeling, biosignals, markers of volume status, and machine learning.
Dr. Heather Patton is a Transplant Hepatologist and the Section Chief of Gastroenterology for the VA San Diego Healthcare System. She currently serves as the Chair of the Hepatology Field Advisory Board to the VHA National Gastroenterology and Hepatology Program Office. In this capacity, she works with subcommittees addressing steatotic liver disease, cirrhosis, and hepatocellular carcinoma to serve as subject matter experts, develop policy, and represent the interests of VA specialty providers in the care of veterans with liver disease.
Associate Professor of Medicine in the Section of Digestive Diseases, Yale School of Medicine.
Clinical and research interest in autoimmune and cholestatic liver diseases. Associate Director of the Clinical and Translational Core of the Yale Liver Center.
GI fellowship Program Director.
Monika Sarkar is a Professor of Hepatology/Liver Transplant at UCSF where she runs the UCSF Women's Liver Program and multidisciplinary liver disease in pregnancy clinic. Her clinical and NIH-funded research program is focused on reproductive health in liver disease, with particular interest in MASLD and autoimmune liver disease, She is former chair of the AASLD Women's Committee, and current chair of the AST Women's Health Community of Practice. She currently serves on the AASLD Nominations Committee.
Dr. Civan is a transplant hepatologist at Thomas Jefferson University in Philadelphia. He has clinical and research interests in hepatocellular carcinoma.
Dr. David E. Kaplan is an Professor of Medicine and Director of Hepatology at the Perelman School of Medicine at the University of Pennsylvania. Dr. Kaplan has served as Director of Hepatology at the Corporal Michael J. Crescenz Veterans Administration Medical Center where he has organized a regional hepatocellular carcinoma tumor board since 2014 with innovations recognized by the VA Diffusion of Excellence program. He has held multiple committee leadership roles in the AASLD including being the current Chairperson of the Liver Cancer SIG. He is an active clinician and mentor.
Allison Kwong, MD, is a hepatologist who specializes in the care of patients with chronic liver disease. Her research in alcohol-associated liver disease has been supported by the AASLD Foundation Clinical, Translational, and Outcomes Research Award and a NIAAA K23 Mentored Career Development Award. Her clinical and research interests include cirrhosis, portal hypertension, and outcomes before and after liver transplantation.
Dr. Cotter is a transplant and general hepatologist at the University of Texas Southwestern Medical Center in Dallas, Texas, having joined on faculty in 2021. He has a strong clinical interest in all aspects of liver diseases and liver transplantation, with a particular focus on alcohol-associated liver disease(ALD). In tandem with his clinical practice, Dr. Cotter has developed a strong clinical research aimed at improving outcomes of patients with ALD. He was a AASLD CTORA recipient through this year and has active NIH (NIAAA - K23AA031310) funding through his K award.
Kristine Drozd, MSN, NP-C, APRN
Senior Nurse Practitioner II
Yale-New Haven Health
Yale Medicine Section of Digestive Health
Hepatology
Robin is a Family Nurse Practitioner with over 24 years of clinical experience. She received her MSN from The Johns Hopkins School of Nursing where she was a National Health Service Corps Scholar and a Peace Corps Fellow. Robin celebrated 8 years as a hepatology NP at UC San Diego Health in August of this year.